Fintel reports that on November 14, 2024, Rodman & Renshaw initiated coverage of Achieve Life Sciences (NasdaqCM:ACHV) with a ...

The true function of our endocannabinoid system has been obscured by its name. It has no essential relationship to cannabis ...

A healthy brain balances "activate" and "inhibit" signaling in its neural microcircuitry, with the inhibitory signaling often provided by cell ...

Neuroscientist Dr Andrija Sente, who conducted his award-winning research at the Medical Research Council Laboratory of ...

Cytisinicline has been granted Breakthrough Therapy designation to address this critical need. Cytisinicline is a plant-based alkaloid with a high binding affinity to the nicotinic acetylcholine ...

A healthy brain balances “activate” and “inhibit” signaling in its neural microcircuitry, with the inhibitory signaling often provided by cell receptors for the neurotransmitter GABA.   Unexpected ...

Antipsychotics can also cause weight gain, metabolic dysfunction, and hormonal problems. Activating muscarinic receptors in ...

A team of scientists at HSE University, in collaboration with the Institute of Higher Nervous Activity and Neurophysiology of ...

AbbVie faces setback as schizophrenia trial for emraclidine fails, but still has potential with other assets from Cerevel.

In the EMPOWER trials, emraclidine was well-tolerated with a safety profile comparable to that observed in the Phase 1b trial. The most commonly reported adverse events in EMPOWER-1 and EMPOWER-2, ...

In a report released today, Joseph Thome from TD Cowen maintained a Buy rating on Rapport Therapeutics, Inc. (RAPP – Research Report).